loading
전일 마감가:
$6.76
열려 있는:
$6.72
하루 거래량:
1.58M
Relative Volume:
0.90
시가총액:
$517.80M
수익:
$14.79M
순이익/손실:
$-102.44M
주가수익비율:
-2.1974
EPS:
-3.04
순현금흐름:
$-91.73M
1주 성능:
+15.37%
1개월 성능:
+37.59%
6개월 성능:
+108.10%
1년 성능:
-24.43%
1일 변동 폭
Value
$6.6429
$7.12
1주일 범위
Value
$5.74
$7.12
52주 변동 폭
Value
$2.41
$10.37

솔리드 바이오 Stock (SLDB) Company Profile

Name
명칭
Solid Biosciences Inc
Name
전화
617-337-4680
Name
주소
500 RUTHERFORD AVENUE, CHARLESTOWN, MA
Name
직원
100
Name
트위터
@SolidBioDMD
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
SLDB's Discussions on Twitter

SLDB을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
SLDB
Solid Biosciences Inc
6.68 482.92M 14.79M -102.44M -91.73M -3.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

솔리드 바이오 Stock (SLDB) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-26 개시 Citigroup Buy
2025-01-08 개시 Truist Buy
2024-12-13 개시 Wedbush Outperform
2024-12-10 개시 JMP Securities Mkt Outperform
2024-07-15 업그레이드 JP Morgan Neutral → Overweight
2024-06-24 업그레이드 Leerink Partners Market Perform → Outperform
2024-05-31 재개 Piper Sandler Overweight
2024-03-28 개시 William Blair Outperform
2024-03-15 개시 Citigroup Buy
2024-03-14 업그레이드 Piper Sandler Neutral → Overweight
2023-12-08 개시 H.C. Wainwright Buy
2021-07-12 개시 Piper Sandler Neutral
2021-05-27 개시 Jefferies Buy
2021-03-16 업그레이드 SVB Leerink Mkt Perform → Outperform
2021-03-09 개시 Barclays Overweight
2021-01-08 업그레이드 Credit Suisse Underperform → Neutral
2020-07-28 다운그레이드 SVB Leerink Outperform → Mkt Perform
2020-05-07 다운그레이드 Evercore ISI Outperform → In-line
2019-10-11 개시 Evercore ISI Outperform
2019-08-29 다운그레이드 Citigroup Neutral → Sell
2019-08-19 업그레이드 SVB Leerink Mkt Perform → Outperform
2019-08-16 업그레이드 Chardan Capital Markets Neutral → Buy
2019-05-14 다운그레이드 Credit Suisse Neutral → Underperform
2019-05-14 다운그레이드 Goldman Neutral → Sell
2019-02-08 업그레이드 Citigroup Sell → Neutral
2019-02-08 다운그레이드 SVB Leerink Outperform → Mkt Perform
2018-11-06 개시 Citigroup Sell
2018-09-06 개시 Credit Suisse Neutral
모두보기

솔리드 바이오 주식(SLDB)의 최신 뉴스

pulisher
01:24 AM

Solid Biosciences Inc. Stock Analysis and ForecastExplosive capital gains - Autocar Professional

01:24 AM
pulisher
Jul 24, 2025

Is Solid Biosciences Inc. a good long term investmentFree Expert Stock Watchlist - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Solid Biosciences Receives FDA Fast Track Designation for - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

Solid Biosciences and the Breakthrough Potential of SGT-501 for CPVT: A Rare Disease Play with Explosive Upside - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Solid Bio gets FDA fast track status for heart disease drug - Seeking Alpha

Jul 23, 2025
pulisher
Jul 23, 2025

Solid Bio Green on Fast Track Nod - Baystreet.ca

Jul 23, 2025
pulisher
Jul 23, 2025

Solid Biosciences receives FDA Fast Track designation for CPVT therapy - Investing.com

Jul 23, 2025
pulisher
Jul 23, 2025

Solid Biosciences Receives FDA Fast Track Designation for SGT-501 First-in-Class Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) - Yahoo Finance

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Solid Biosciences Inc. stock priceFree Trading Psychology Coaching - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Cantor Fitzgerald Reaffirms Their Buy Rating on Solid Biosciences (SLDB) - The Globe and Mail

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Solid Biosciences Inc. stockFree Smart Trading Workshop - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Solid Biosciences (SLDB) Soars 8.76% on FDA Approval - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Solid Biosciences Inc. shares rise 3.29% premarket after Senti Bio's presentation at BioScience Forum. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Cantor Fitzgerald reiterates Overweight rating on Solid Biosciences stock By Investing.com - Investing.com Canada

Jul 21, 2025
pulisher
Jul 21, 2025

Solid Biosciences stock rating reiterated at Market Outperform by JMP - Investing.com Canada

Jul 21, 2025
pulisher
Jul 19, 2025

What institutions are buying Solid Biosciences Inc. stock nowSteady Income Ideas - beatles.ru

Jul 19, 2025
pulisher
Jul 18, 2025

Solid Biosciences’ SWOT analysis: gene therapy stock shows promise amid challenges - Investing.com Nigeria

Jul 18, 2025
pulisher
Jul 17, 2025

Citi maintains Buy rating on Solid Biosciences stock amid Elevidys safety concerns - Investing.com Canada

Jul 17, 2025
pulisher
Jul 16, 2025

Why Solid Biosciences Inc. stock attracts strong analyst attentionSolid Return Trade Selections - beatles.ru

Jul 16, 2025
pulisher
Jul 15, 2025

Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Solid Biosciences (SLDB) and Belite Bio, Inc. ADR (BLTE) - The Globe and Mail

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Solid Biosciences Inc. stock price move sharplyFree Investment Group - beatles.ru

Jul 15, 2025
pulisher
Jul 12, 2025

Cantor Fitzgerald Remains a Buy on Solid Biosciences (SLDB) - The Globe and Mail

Jul 12, 2025
pulisher
Jul 11, 2025

Solid Biosciences: SGT-003's Safety Profile Illuminates DMD Gene Therapy Path (Rating Upgrade) - Seeking Alpha

Jul 11, 2025
pulisher
Jul 10, 2025

Truist Financial Reaffirms Their Buy Rating on Solid Biosciences (SLDB) - The Globe and Mail

Jul 10, 2025
pulisher
Jul 10, 2025

SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Solid Biosciences Inc. (NASDAQ: SLDB) and Encourages Long-Term SLDB Investors to Contact the Firm - The Victoria Advocate

Jul 10, 2025
pulisher
Jul 10, 2025

For Patients - Solid Biosciences

Jul 10, 2025

솔리드 바이오 (SLDB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
자본화:     |  볼륨(24시간):